Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | +5.50% | +4.55% | -20.69% |
Evolution of the average Target Price on Rigel Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Rigel Pharmaceuticals, Inc.
Citigroup | |
B. Riley | |
Piper Sandler | |
HC Wainwright | |
Cantor Fitzgerald | |
Jefferies & Co. | |
BMO Capital |
EPS Revisions
- Stock Market
- Equities
- RIGL Stock
- Consensus Rigel Pharmaceuticals, Inc.